Table 3. Summary of Transplanted MNC,... | American Society of Hematology

Table 3.

Summary of Transplanted MNC, CFU-GM, and Hematologic Recovery

No.	MNC (×10⁷/kg)			CFU-GM (×10⁴/kg)			Days to Neutrophils >500/μL	Days to Platelets >5 × 10⁴/μL
No.	Transduced	Untransduced	Total	Transduced	Untransduced	Total	Days to Neutrophils >500/μL	Days to Platelets >5 × 10⁴/μL
1	—	7.8	7.8	—	5.9	5.9	35	28
2	4.0	3.0	7.0	1.5	2.5	4.0	25	28
				(6.7%)^3-150		(2.5%)^3-151
3	5.7	2.8	8.5	2.5	3.3	5.8	39	39
				(5.9%)^3-150		(2.1%)^3-151
4	6.9	1.1	8.0	8.1	4.4	12.5	33	33
				(13.7%)^3-150		(8.9%)^3-151

No.	MNC (×10⁷/kg)			CFU-GM (×10⁴/kg)			Days to Neutrophils >500/μL	Days to Platelets >5 × 10⁴/μL
No.	Transduced	Untransduced	Total	Transduced	Untransduced	Total	Days to Neutrophils >500/μL	Days to Platelets >5 × 10⁴/μL
1	—	7.8	7.8	—	5.9	5.9	35	28
2	4.0	3.0	7.0	1.5	2.5	4.0	25	28
				(6.7%)^3-150		(2.5%)^3-151
3	5.7	2.8	8.5	2.5	3.3	5.8	39	39
				(5.9%)^3-150		(2.1%)^3-151
4	6.9	1.1	8.0	8.1	4.4	12.5	33	33
				(13.7%)^3-150		(8.9%)^3-151

Animal No. 1 was transplanted only with untransduced PBPC as a control.

Transduction efficiency (percentage of VCR resistant colonies).

Transduction efficiency was calculated from the numbers of transduced and untransduced CFU-GM.